Infectious Diseases (except HIV/AIDS)

  1. Commercial stocks of SARS-CoV-2 RNA may report low concentration values, leading to artificially increased apparent sensitivity of diagnostic assays

    1. Erik Jue
    2. Rustem F. Ismagilov

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Global academic response to COVID ‐19: Cross‐sectional study

    1. Jack A. Helliwell
    2. William S. Bolton
    3. Joshua R. Burke
    4. Jim P. Tiernan
    5. David G. Jayne
    6. Stephen J. Chapman

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection

    1. Christoph B. Messner
    2. Vadim Demichev
    3. Daniel Wendisch
    4. Laura Michalick
    5. Matthew White
    6. Anja Freiwald
    7. Kathrin Textoris-Taube
    8. Spyros I. Vernardis
    9. Anna-Sophia Egger
    10. Marco Kreidl
    11. Daniela Ludwig
    12. Christiane Kilian
    13. Federica Agostini
    14. Aleksej Zelezniak
    15. Charlotte Thibeault
    16. Moritz Pfeiffer
    17. Stefan Hippenstiel
    18. Andreas Hocke
    19. Christof von Kalle
    20. Archie Campbell
    21. Caroline Hayward
    22. David J. Porteous
    23. Riccardo E. Marioni
    24. Claudia Langenberg
    25. Kathryn S. Lilley
    26. Wolfgang M. Kuebler
    27. Michael Mülleder
    28. Christian Drosten
    29. Norbert Suttorp
    30. Martin Witzenrath
    31. Florian Kurth
    32. Leif Erik Sander
    33. Markus Ralser

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Pre-test probability for SARS-Cov-2-related infection score: The PARIS score

    1. Mickael Tordjman
    2. Ahmed Mekki
    3. Rahul D. Mali
    4. Ines Saab
    5. Guillaume Chassagnon
    6. Enora Guillo
    7. Robert Burns
    8. Deborah Eshagh
    9. Sebastien Beaune
    10. Guillaume Madelin
    11. Simon Bessis
    12. Antoine Feydy
    13. Fadila Mihoubi
    14. Benoit Doumenc
    15. Luc Mouthon
    16. Robert-Yves Carlier
    17. Jean-Luc Drapé
    18. Marie-Pierre Revel

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Predictive value of sudden olfactory loss in the diagnosis of COVID-19

    1. Antje Haehner
    2. Julia Draf
    3. Sarah Dräger
    4. Katja de With
    5. Thomas Hummel

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Direct Observation of Repeated Infections With Endemic Coronaviruses

    1. Marta Galanti
    2. Jeffrey Shaman

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19)

    1. Katja Radon
    2. Elmar Saathoff
    3. Michael Pritsch
    4. Jessica Michelle Guggenbühl Noller
    5. Inge Kroidl
    6. Laura Olbrich
    7. Verena Thiel
    8. Max Diefenbach
    9. Friedrich Riess
    10. Felix Forster
    11. Fabian Theis
    12. Andreas Wieser
    13. Michael Hoelscher
    14. the KoCo19 collaboration group
    15. Abhishek Bakuli
    16. Judith Eckstein
    17. Günter Froeschl
    18. Otto Geisenberger
    19. Christof Geldmacher
    20. Arlett Heiber
    21. Larissa Hoffmann
    22. Kristina Huber
    23. Dafni Metaxa
    24. Michel Pletschette
    25. Camilla Rothe
    26. Mirjam Schunk
    27. Claudia Wallrauch
    28. Thorbjörn Zimmer
    29. Stephan Prückner
    30. Christiane Fuchs
    31. Jan Hasenauer
    32. Noemi Castelletti
    33. Eleftheria Zeggini
    34. Michael Laxy
    35. Reiner Leidl
    36. Lars Schwettmann

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection

    1. Asmaa Hachim
    2. Niloufar Kavian
    3. Carolyn A. Cohen
    4. Alex W. H. Chin
    5. Daniel K. W. Chu
    6. Chris K. P. Mok
    7. Owen T. Y. Tsang
    8. Yiu Cheong Yeung
    9. Ranawaka A. P. M. Perera
    10. Leo L. M. Poon
    11. J. S. Malik Peiris
    12. Sophie A. Valkenburg

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Early Viral Clearance and Antibody Kinetics of COVID-19 Among Asymptomatic Carriers

    1. Tongyang Xiao
    2. Yanrong Wang
    3. Jing Yuan
    4. Haocheng Ye
    5. Lanlan Wei
    6. Xuejiao Liao
    7. Haiyan Wang
    8. Shen Qian
    9. Zhaoqin Wang
    10. Lei Liu
    11. Zheng Zhang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients

    1. Maia Norman
    2. Tal Gilboa
    3. Alana F. Ogata
    4. Adam M. Maley
    5. Limor Cohen
    6. Yongfei Cai
    7. Jun Zhang
    8. Jared E. Feldman
    9. Blake M. Hauser
    10. Timothy M. Caradonna
    11. Bing Chen
    12. Aaron G. Schmidt
    13. Galit Alter
    14. Richelle C. Charles
    15. Edward T. Ryan
    16. David R. Walt

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 96 of 716 Next